3,298
Views
39
CrossRef citations to date
0
Altmetric
Original Research

Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model

, , , , , , , & show all
Article: e1090075 | Received 24 Jun 2015, Accepted 29 Aug 2015, Published online: 21 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Inés Lecoq, Katharina L. Kopp, Marion Chapellier, Panagiotis Mantas, Evelina Martinenaite, Maria Perez-Penco, Lars Rønn Olsen, Mai-Britt Zocca, Ayako Wakatsuki Pedersen & Mads Hald Andersen. (2022) CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment. OncoImmunology 11:1.
Read now
Aude Burlion, Rodrigo N. Ramos, Pukar KC, Kélhia Sendeyo, Aurélien Corneau, Christine Ménétrier-Caux, Eliane Piaggio, Daniel Olive, Christophe Caux & Gilles Marodon. (2019) A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune system. OncoImmunology 8:7.
Read now
Sonja Lieber, Silke Reinartz, Hartmann Raifer, Florian Finkernagel, Tobias Dreyer, Holger Bronger, Julia M. Jansen, Uwe Wagner, Thomas Worzfeld, Rolf Müller & Magdalena Huber. (2018) Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells. OncoImmunology 7:5.
Read now
Elizabeth Magnotti & Wayne A. Marasco. (2018) The latest animal models of ovarian cancer for novel drug discovery. Expert Opinion on Drug Discovery 13:3, pages 249-257.
Read now
Mariona Cabo, Rienk Offringa, Laurence Zitvogel, Guido Kroemer, Aura Muntasell & Lorenzo Galluzzi. (2017) Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. OncoImmunology 6:12.
Read now

Articles from other publishers (34)

Jihyun Kim, Jocelyn V. Pena, Hannah P. McQueen, Lingwei Kong, Dina Michael, Elmira M. Lomashvili & Pamela R. Cook. (2023) Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA. Cancer Gene Therapy.
Crossref
Peizhen Lao, Jingyi Chen, Longqian Tang, Jiwen Zhang, Yuxi Chen, Yuyin Fang & Xingliang Fan. (2023) Regulatory T cells in lung disease and transplantation. Bioscience Reports 43:10.
Crossref
Hongbo Ni & Yinghan Chen. (2023) Differentiation, regulation and function of regulatory T cells in non-lymphoid tissues and tumors. International Immunopharmacology 121, pages 110429.
Crossref
Zikun Peng, Ming Li, Huayi Li & Qinglei Gao. (2023) PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities. Drug Discovery Today 28:8, pages 103666.
Crossref
Aydar Khabipov, Dung Nguyen Trung, Julia van der Linde, Lea Miebach, Maik Lenz, Felix Erne, Wolfram von Bernstorff, Tobias Schulze, Stephan Kersting, Sander Bekeschus & Lars Ivo Partecke. (2023) CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice. Biomedicines 11:6, pages 1517.
Crossref
Mara P. Steinkamp, Irina Lagutina, Kathryn J. Brayer, Fred Schultz, Danielle Burke, Vernon S. Pankratz, Sarah F. Adams, Laurie G. Hudson, Scott A. Ness & Angela Wandinger-Ness. (2023) Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity. Cancer Research Communications 3:2, pages 309-324.
Crossref
Diana Luísa Almeida-Nunes, Ana Mendes-Frias, Ricardo Silvestre, Ricardo Jorge Dinis-Oliveira & Sara Ricardo. (2022) Immune Tumor Microenvironment in Ovarian Cancer Ascites. International Journal of Molecular Sciences 23:18, pages 10692.
Crossref
Alessandra Ciucci, Marianna Buttarelli, Anna Fagotti, Giovanni Scambia & Daniela Gallo. (2022) Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application. Cellular and Molecular Life Sciences 79:7.
Crossref
Katrin Kleinmanns, Stein-Erik Gullaksen, Geir Bredholt, Ben Davidson, Cecilie Fredvik Torkildsen, Sindre Grindheim, Line Bjørge & Emmet McCormack. (2022) Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies. Cancers 14:13, pages 3092.
Crossref
Juyeun Lee, Dongkyun Kim & Booki Min. (2022) Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease. Frontiers in Immunology 13.
Crossref
Nathan Karin. (2021) Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?. Cancers 13:24, pages 6317.
Crossref
Osamu Yoshie. (2021) CCR4 as a Therapeutic Target for Cancer Immunotherapy. Cancers 13:21, pages 5542.
Crossref
Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami, Mehrdad Fathi, Mehran Mohammadpour Saray, Leili Aghebati-Maleki, Reza Jafari, Naime Majidi Zolbanin & Farhad Jadidi-Niaragh. (2021) The role of regulatory T cells in the pathogenesis and treatment of prostate cancer. Life Sciences 284, pages 119132.
Crossref
Jhalak Dholakia, Carly Scalise & Rebecca C. Arend. (2021) Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies. Cancers 13:7, pages 1694.
Crossref
Courtney T. Stump, Gregory Ho, Chenkai Mao, Frank A. Veliz, Veronique Beiss, Jennifer Fields, Nicole F. Steinmetz & Steven Fiering. (2021) Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth. Cancers 13:4, pages 627.
Crossref
Amy L. Wilson, Laura R. Moffitt, Kirsty L. Wilson, Maree Bilandzic, Mark D. Wright, Mark D. Gorrell, Martin K. Oehler, Magdalena Plebanski & Andrew N. Stephens. (2021) DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model. Cancers 13:3, pages 487.
Crossref
H. Ryan Kolb, Nicholas Borcherding & Weizhou Zhang. 2021. T Regulatory Cells in Human Health and Diseases. T Regulatory Cells in Human Health and Diseases 229 256 .
Alejandra Martinez, Jean-Pierre Delord, Maha Ayyoub & Christel Devaud. (2020) Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer. Cancers 12:7, pages 1761.
Crossref
David A. Baran, Prakash Rao, Dayanand Deo & Mark J. Zucker. (2020) Differential gene expression in non‐adherent heart transplant survivors: Implications for regulatory T‐cell expression. Clinical Transplantation 34:5.
Crossref
Elizabeth L. Magnotti, Leo Li-Ying Chan, Quan Zhu & Wayne A. Marasco. (2020) A high-throughput chemotaxis detection method for CCR4+ T cell migration inhibition using image cytometry. Journal of Immunological Methods 479, pages 112747.
Crossref
Justin A. Chen, Weijie Ma, Jianda Yuan & Tianhong Li. 2020. Tumor Microenvironment. Tumor Microenvironment 251 279 .
Christina M. Paluskievicz, Xuefang Cao, Reza Abdi, Pan Zheng, Yang Liu & Jonathan S. Bromberg. (2019) T Regulatory Cells and Priming the Suppressive Tumor Microenvironment. Frontiers in Immunology 10.
Crossref
Abdollah Jafarzadeh, Maryam Nemati & Sara Jafarzadeh. (2019) The important role played by chemokines influence the clinical outcome of Helicobacter pylori infection. Life Sciences 231, pages 116688.
Crossref
Thorsten R. Mempel & Francesco Marangoni. (2019) Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response. Immunological Reviews 289:1, pages 129-141.
Crossref
Amir Sharabi, Maria G. Tsokos, Ying Ding, Thomas R. Malek, David Klatzmann & George C. Tsokos. (2018) Regulatory T cells in the treatment of disease. Nature Reviews Drug Discovery 17:11, pages 823-844.
Crossref
Boyi Zhang, Fei Chen, Qixia Xu, Liu Han, Jiaqian Xu, Libin Gao, Xiaochen Sun, Yiwen Li, Yan Li, Min Qian & Yu Sun. (2017) Revisiting ovarian cancer microenvironment: a friend or a foe?. Protein & Cell 9:8, pages 674-692.
Crossref
Curtis McCloskey, Galaxia Rodriguez, Kristianne Galpin & Barbara Vanderhyden. (2018) Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics. Cancers 10:8, pages 244.
Crossref
Carlos Cuesta-Mateos, Ana Alcaraz-Serna, Beatriz Somovilla-Crespo & Cecilia Muñoz-Calleja. (2018) Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets. Frontiers in Immunology 8.
Crossref
Lydia Visser, Arjan Diepstra, Christian Steidl & Anke van den Berg. 2018. Precision Molecular Pathology of Hodgkin Lymphoma. Precision Molecular Pathology of Hodgkin Lymphoma 59 90 .
Yuki Muroyama, Thomas R. Nirschl, Christina M. Kochel, Zoila Lopez-Bujanda, Debebe Theodros, Wendy Mao, Maria A. Carrera-Haro, Ali Ghasemzadeh, Ariel E. Marciscano, Esteban Velarde, Ada J. Tam, Christopher J. Thoburn, Muniza Uddin, Alan K. Meeker, Robert A. Anders, Drew M. Pardoll & Charles G. Drake. (2017) Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment. Cancer Immunology Research 5:11, pages 992-1004.
Crossref
Lydia Dyck & Kingston H.G. Mills. (2017) Immune checkpoints and their inhibition in cancer and infectious diseases. European Journal of Immunology 47:5, pages 765-779.
Crossref
Thomas Worzfeld, Elke Pogge von Strandmann, Magdalena Huber, Till Adhikary, Uwe Wagner, Silke Reinartz & Rolf Müller. (2017) The Unique Molecular and Cellular Microenvironment of Ovarian Cancer. Frontiers in Oncology 7.
Crossref
R.A. Lacalle, R. Blanco, L. Carmona-Rodríguez, A. Martín-Leal, E. Mira & S. Mañes. 2017. 181 244 .
Smitha Menon, Sarah Shin & Grace Dy. (2016) Advances in Cancer Immunotherapy in Solid Tumors. Cancers 8:12, pages 106.
Crossref